Skip to content
Screener

Delcath Systems DCTH Operating Income

Operating Income at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$44.16M+7.6%
Boston Scientific logo
Boston ScientificBSX
$1.18B+43.8%
Altimmune logo
AltimmuneALT
-$24.24M-11.1%
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
-$8.41M-14.8%
Wave Life Sciences logo
Wave Life SciencesWVE
-$73.8M-39.9%
CTO
Citius Oncology, Inc.CTOR
-$28.61M-283%

Other financials

Income statement

See full
Revenue$29.1M+20.6%
Gross profit$26.1M+25.5%
Net income$2.7M-1.1%
EPS (diluted)$0.070.0%

Balance sheet

See full
Cash & equivalents$47.5M+38.0%
Total debt$2.5M+148%
Total equity$121.1M+15.4%
Total assets$137.0M+17.2%

Cash flow

See full
Operating cash flow$5.7M-21.7%
CapEx$503.0K+26.4%
Free cash flow$5.2M-24.5%

Valuation

See full
Market cap$524.3M+42.6%
Enterprise value$479.26M+43.4%
P/E102.3×
P/S5.5×+0.3×

Profitability

See full
Gross margin87.1%+1.2pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin18.3%+12.8pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio9.8×-1.0×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Delcath Systems’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 9:09 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053956
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Research and development expenses10,3806,88220,20411,889
Selling, general and administrative expenses13,37311,36626,44422,656
Total operating expenses23,75318,24846,64834,545
Operating income2,3952,5907583,232
Interest income7816491,5681,267
Other expense(17)(34)(75)(30)
Income before income taxes3,1593,2052,2514,469
Income tax expense491508653703

Item 1. Financial Statements

FAQ

What is Delcath Systems's operating income?
Delcath Systems (DCTH) reported operating income of $2.4M in Q2 2026.
How has Delcath Systems's operating income changed year-over-year?
Delcath Systems's operating income decreased by 7.5% year-over-year, from $2.59M to $2.4M.
What is the long-term trend for Delcath Systems's operating income?
Over 2 years (2021 to 2023), Delcath Systems's operating income has grown at a 24.8% compound annual growth rate (CAGR), from -$24.53M to -$38.18M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Delcath Systems's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude